Literature DB >> 20625757

Factors associated with long-term functional outcomes and psychological sequelae in Guillain-Barre syndrome.

F Khan1, J F Pallant, L Ng, A Bhasker.   

Abstract

UNLABELLED: To examine factors impacting long-term health-related outcomes in survivors of Guillain-Barre syndrome (GBS). Seventy-six consecutive patients with definite GBS admitted to the Royal Melbourne Hospital (1996-2009) were reviewed in the neurorehabilitation clinics. They underwent a structured interview designed to assess the impact of GBS on their current activity and restriction in participation using validated questionnaires: Functional Independence Measure (FIM), Perceived Impact of Problem Profile (PIPP) and Depression Anxiety Stress Scale (DASS). Their sociodemographic and disease severity data were obtained from the medical record. The 76 patients [60% male, mean age 56 years, median time since GBS 6 years (range 1-14 years)] showed good functional recovery (median motor FIM score 90). However, 16% reported moderate to extreme impact on their ability to participate in work, family, and social activities; and 22% substantial impact on mood, confidence and ability to live independently. More reported moderate to extreme depression (18%), anxiety (22%) and stress (17%) compared with the normative Australian population (13%). Factors associated with poorer current level of functioning and wellbeing included: females, older patients (57+ years), acute hospital stay (>11 days), those treated in intensive care and those discharged to rehabilitation. No associations were found between the Medical Research Council (MRC) Motor Scale Rating scores at admission, nor time since GBS diagnosis (≤6 vs. >6 years) on outcomes used.
CONCLUSION: GBS is complex and requires long-term management of psychological sequelae impacting activity and participation.

Entities:  

Mesh:

Year:  2010        PMID: 20625757     DOI: 10.1007/s00415-010-5653-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

1.  Long-term impact on work and private life after Guillain-Barré syndrome.

Authors:  Robert A J A M Bernsen; Aeiko E J de Jager; Paul I M Schmitz; Frans G A van der Meché
Journal:  J Neurol Sci       Date:  2002-09-15       Impact factor: 3.181

Review 2.  Rehabilitation of Guillain-Barré syndrome.

Authors:  J M Meythaler
Journal:  Arch Phys Med Rehabil       Date:  1997-08       Impact factor: 3.966

3.  Guillain-Barré syndrome: incidence and mortality rates in US hospitals.

Authors:  Amer Alshekhlee; Zulfiqar Hussain; Badr Sultan; Bashar Katirji
Journal:  Neurology       Date:  2008-04-29       Impact factor: 9.910

Review 4.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

5.  A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.

Authors:  J B Winer; R A Hughes; C Osmond
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

Review 6.  The epidemiology of Guillain-Barré syndrome.

Authors:  M Alter
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

7.  Functional assessment scales: a study of persons with multiple sclerosis.

Authors:  C V Granger; A C Cotter; B B Hamilton; R C Fiedler; M M Hens
Journal:  Arch Phys Med Rehabil       Date:  1990-10       Impact factor: 3.966

8.  How Guillain-Barre patients experience their functioning after 1 year.

Authors:  Robert A J A M Bernsen; Aeiko E J de Jager; Frans G A van der Meché; Theo P B M Suurmeijer
Journal:  Acta Neurol Scand       Date:  2005-07       Impact factor: 3.209

9.  A review of the management of Guillain-Barré syndrome in a regional neurological rehabilitation unit.

Authors:  Aine Carroll; Gavin McDonnell; Mike Barnes
Journal:  Int J Rehabil Res       Date:  2003-12       Impact factor: 1.479

Review 10.  Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.

Authors:  Pieter A van Doorn; Liselotte Ruts; Bart C Jacobs
Journal:  Lancet Neurol       Date:  2008-10       Impact factor: 44.182

View more
  12 in total

Review 1.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

2.  Observer blind randomised controlled trial of a tailored home exercise programme versus usual care in people with stable inflammatory immune mediated neuropathy.

Authors:  Claire M White; Robert D Hadden; Sarah F Robert-Lewis; Paul R McCrone; Jane L Petty
Journal:  BMC Neurol       Date:  2015-08-21       Impact factor: 2.474

3.  Functional outcomes and efficiency of rehabilitation in a national cohort of patients with Guillain-Barré syndrome and other inflammatory polyneuropathies.

Authors:  Roxana Alexandrescu; Richard John Siegert; Lynne Turner-Stokes
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

Review 4.  Depressive Syndromes in Autoimmune Disorders of the Nervous System: Prevalence, Etiology, and Influence.

Authors:  Yanjun Liu; Xiangqi Tang
Journal:  Front Psychiatry       Date:  2018-09-25       Impact factor: 4.157

Review 5.  Psychiatric Sequelae of Guillain-Barré Syndrome: Towards a Multidisciplinary Team Approach.

Authors:  Christopher Hillyar; Anjan Nibber
Journal:  Cureus       Date:  2020-02-19

6.  Patients' experiences and perceptions of Guillain-Barré syndrome: A systematic review and meta-synthesis of qualitative research.

Authors:  Despina Laparidou; Ffion Curtis; Joseph Akanuwe; Jennifer Jackson; Timothy L Hodgson; A Niroshan Siriwardena
Journal:  PLoS One       Date:  2021-02-03       Impact factor: 3.240

7.  Relevance of anxiety in clinical practice of Guillain-Barre syndrome: a cohort study.

Authors:  Tarek Sharshar; Andrea Polito; Raphaël Porcher; Takoua Merhbene; Morgane Blanc; Marion Antona; Marie-Christine Durand; Diane Friedman; David Orlikowski; Djillali Annane; Marie-Hélène Marcadet
Journal:  BMJ Open       Date:  2012-08-24       Impact factor: 2.692

8.  Guillain-Barré syndrome: prevalence and long-term factors impacting bladder function in an Australian community cohort.

Authors:  Bhasker Amatya; Fary Khan; Michael Whishaw; Julie F Pallant
Journal:  J Clin Neurol       Date:  2013-07-01       Impact factor: 3.077

Review 9.  Neuropsychiatric manifestations in inflammatory neuropathies: A systematic review.

Authors:  Yusuf A Rajabally; Stefano Seri; Andrea E Cavanna
Journal:  Muscle Nerve       Date:  2016-05-10       Impact factor: 3.217

10.  Exploring the experiences of having Guillain-Barré Syndrome: A qualitative interview study.

Authors:  Joseph N A Akanuwe; Despina Laparidou; Ffion Curtis; Jennifer Jackson; Timothy L Hodgson; Aloysius Niroshan Siriwardena
Journal:  Health Expect       Date:  2020-08-03       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.